Skip to main content

Table 1 Baseline characteristics

From: Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study

Characteristics (N = 136 DM patients)  
Age (years) 65.3 ± 9.28
Women n, (%) 53 (39.0)
Body mass index (kg/m2) 26.94 ± 3.01
Blood pressure (mmHg)
 Systolic blood pressure 133.34 ± 15.66
 Diastolic blood pressure 78.98 ± 8.82
Risk factors
 Hypertention n, (%) 102 (75.0)
 Hyperlipidemia n, (%) 78 (57.4)
 Smoking n, (%) 54 (39.7)
LVEF (%) 63.79 ± 6.28
Clinical presentation
 Stable angina n, (%) 45 (33.1)
 Unstable angina n, (%) 63 (46.3)
 Acute myocardial infarction n, (%) 24 (17.7)
 Old myocardial infarction n, (%) 4 (2.9)
Target vessels n (%)
 LAD 77 (53.8)
 LCX 20 (14.0)
 RCA 46 (32.2)
Laboratory study
 Total cholesterol (mmol/L) 4.27 ± 1.00
 Triglycerides (mmol/L) 2.18 ± 1.27
 HDL-C (mmol/L) 1.08 ± 0.25
 LDL-C (mmol/L) 2.42 ± 0.85
 Apo-A (mmol/L) 1.13 ± 0.18
 Apo-B (mmol/L) 0.90 ± 0.22
 Lp (a) (g/L) 0.19 ± 0.15
 Fast glucose (mmol/L) 7.55 ± 2.50
 BUN (mmol/L) 5.98 ± 1.65
 Creatinine (mg/L) 86.19 ± 24.58
 Glycated haemoglobin (%) 7.84 ± 1.51
 hsCRP (mg/L) 5.47 ± 6.11
 esRAGE (ng/ml) 0.20 ± 0.15
 GA (%) 21.63 ± 5.54
Oral hypoglycemic agents n, (%) 112 (82.4)
Insulin n, (%) 31 (22.8)
Duration of DM treatment (years) 11.2 ± 8.5
Antiplatalet n, (%) 136 (100)
Statins n, (%) 132 (97.1)
  1. DM, diabetes mellitus; LVEF, left ventricle ejection fraction; LAD, left anterior descending; LCX, left circumsflex; RCA, right coronary artery; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; Apo-A, apolipoprotein-A; Apo-B, apolipoprotein-B; Lp (a), lipoprotein (a); BUN, blood urea nitrogen; hsCRP, high sensitive C-reactive protein; esRAGE, endogenous secretory receptors for advanced glycation endproducts; GA, glycated albumin